Search results
Earnings call: Solaris Oilfield announces Q1 2024 results, maintains dividends By Investing.com
Investing.com· 1 day agoThe company reported revenue of $68 million, adjusted EBITDA of $23 million, and free cash flow of...
SES, Intelsat Revive Deal Talks to Form Satellite Giant
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- SES SA and Intelsat SA have revived discussions on a potential merger to create a...
UBS cuts SoFi stock target, maintains neutral stance By Investing.com
Investing.com· 6 hours agoThe financial services firm reported adjusted net revenue of approximately $581 million, surpassing...
Pros and cons of balance transfer credit cards — a guide
CNN.com· 4 days agoDiscover the pros and cons of balance transfer credit cards and make an informed decision. Learn how...
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
Zacks via Yahoo Finance· 2 hours agoPhilips' (PHG) first-quarter results benefit from strong momentum across the Diagnosis & Treatment...
Gen Z is averaging higher credit scores than millennials: Is it financial competence or just good...
Stacker via AOL· 4 days agoAbout 64% of millennials and 61% of Gen Xers reported they were using their personal loans for debt ...
Tyler Tech shares get price target boost on strong Q1 results By Investing.com
Investing.com· 5 days agoThe revision follows Tyler's report of robust first-quarter earnings, which exceeded both top and...
Fed Meets Today: Watch Out for Interest Rate Hikes Instead of Cuts This Year, One Economist Says
CNET· 5 hours agoIf you figured the Federal Reserve would lower interest rates soon, you may want to prepare for the...
Earnings call: Employers Holdings Q1 2024 revenue up 8%, driven by premiums By Investing.com
Investing.com· 24 hours agoEmployers Holdings, Inc. (NYSE:EIG) has reported an 8% increase in revenue for the first quarter of...
RBC starts Contineum Therapeutics stock with outperform, cites long-term potential By Investing.com
Investing.com· 7 hours agoRBC Capital's analysis suggests that Contineum Therapeutics' scientific approach and clinical...